Sun Pharma jumps into global top 25 as it buys Organon for 11.75 billion

Published on 6 May 2026

One mega deal brings glory and fresh risk

Sun Pharma’s acquisition of Organon in a record $11.75 billion deal propels the company into the world’s top 25 pharma players. While chairman Dilip Shanghvi is excited by the leap in scale and ambition, the moment also carries anxiety—highlighting how even “winning” mergers demand careful execution.

Sun Pharma’s $11.75 billion Organon acquisition boosts global ranking
The deal places the company in the top 25 pharmaceutical firms worldwide
Chairman Dilip Shanghvi feels both excitement and anxiety
Mega M&As can succeed when integration and strategy stay tight

#organon #sun pharma #global expansion #mergers and acquisitions #pharma

Read the full story at The Economic Times

This summarization was done by Beige for a story published on The Economic Times

Sun Pharma jumps into global top 25 as it buys Organon for 11.75 billion

The full experience is on mobile.